Virtu Financial’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Virtu Financial’s Portfolio BLCM Stock Details BLCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-21,792	Closed	-$32K	–	2312
2021 Q4	$32K	Buy	+21,792	New	+$43.9K	﹤0.01%	1436
2019 Q3	–	Sell	-6,816	Closed	-$116K	–	1956
2019 Q2	$116K	Buy	6,816 +5,028	+281%	+$136K	0.01%	1112
2019 Q1	$60K	Sell	1,788 -884	-33%	-$29.5K	﹤0.01%	1199
2018 Q4	$78K	Sell	2,672 -1,195	-31%	-$53K	﹤0.01%	1194
2018 Q3	$238K	Buy	3,867 +2,813	+267%	+$190K	0.01%	984
2018 Q2	$78K	Buy	+1,054	New	+$82.2K	﹤0.01%	1695
2018 Q1	–	Sell	-6,904	Closed	-$581K	–	2799
2017 Q4	$581K	Buy	6,904 +3,968	+135%	+$389K	0.03%	728
2017 Q3	$339K	Buy	+2,936	New	+$309K	0.02%	1269

Other funds holding BLCM

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Virtu Financial's BLCM Position: Q1 2022 in Review

Virtu Financial sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q1 2022, closing a stake of 21,792 shares — an estimated $32K sold.

Virtu Financial first reported a position in BLCM in Q3 2017 and held it in 8 quarters. The position peaked at $581K in Q4 2017. 29 funds tracked by Wall St. Rank hold BLCM as of Q1 2022.

Virtu Financial reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q1 2022 after selling out during the quarter.
Virtu Financial sold 21,792 Bellicum Pharmaceuticals, Inc. shares in Q1 2022, an estimated $32K.
Virtu Financial first reported a position in Bellicum Pharmaceuticals, Inc. in Q3 2017 and held it in 8 quarters.
Virtu Financial's Bellicum Pharmaceuticals, Inc. position peaked at $581K in Q4 2017.
29 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q1 2022.

Based on Virtu Financial's 13F filing for Q1 2022, filed 17 May 2022.